Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.46 is 14% below its 5-year average of 0.54, near the low end of its 5-year range (0.24–1.01).
As of the fiscal period ended Tuesday, June 30, 2026. 38.75% above its 12-month average of 0.33.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.46.
CURRENT RATIO
0.46
CURRENT RATIO AVG TTM
0.33
CURRENT RATIO AVG 3Y
0.47
CURRENT RATIO AVG 5Y
0.54
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+38.75%
CURRENT VS 3Y AVG
-1.52%
CURRENT VS 5Y AVG
-14.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-87.73%
vs the sector median at left
Market Cap
$18.30M
Current Ratio
0.20
TTM Avg
0.34
3Y Avg
6.34
5Y Avg
6.11
Market Cap
$18.65M
Current Ratio
27.85
TTM Avg
15.71
3Y Avg
9.25
5Y Avg
10.43
Market Cap
$19.42M
Current Ratio
1.25
TTM Avg
1.72
3Y Avg
2.15
5Y Avg
2.15
Market Cap
$16.84M
Current Ratio
6.03
TTM Avg
7.38
3Y Avg
5.62
5Y Avg
4.97
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| P3 Health Partners Inc. (PIII) | $18.41M | 0.46 | 0.33 | 0.47 | 0.54 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.30M | 0.20 | 0.34 | 6.34 | 6.11 |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.65M | 27.85 | 15.71 | 9.25 | 10.43 |
| Actuate Therapeutics Inc (ACTU)vs › | $19.42M | 1.25 | 1.72 | 2.15 | 2.15 |
| Cosmos Health Inc. (COSM)vs › | $17.39M | 1.05 | 0.99 | 1.52 | 1.43 |
| Lipocine Inc. (LPCN)vs › | $17.31M | 11.48 | 10.71 | 12.62 | 10.43 |
| PAVmed Inc. (PAVM)vs › | $17.07M | 1.19 | 0.12 | 0.44 | 2.27 |
| Quantum BioPharma Ltd. (QNTM)vs › | $19.77M | 1.20 | 1.44 | 1.90 | 2.95 |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | 6.03 | 7.38 | 5.62 | 4.97 |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.82M | 3.37 | 8.28 | 7.56 | 6.68 |
Current Ratio
0.46
Quick Ratio
0.46
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.46 |
| 2026-03-31 | 0.33 |
| 2025-12-31 | 0.24 |
| 2025-09-30 | 0.32 |
| 2025-06-30 | 0.31 |
| 2025-03-31 | 0.38 |
| 2024-12-31 | 0.37 |
| 2024-09-30 | 0.53 |
| 2024-06-30 | 0.69 |
| 2024-03-31 | 0.55 |
| 2023-12-31 | 0.55 |
| 2023-09-30 | 0.67 |
| 2023-06-30 | 0.69 |
| 2023-03-31 | 0.41 |
| 2022-12-31 | 0.42 |
| 2022-09-30 | 0.55 |
| 2022-06-30 | 0.75 |
| 2022-03-31 | 0.91 |
| 2021-12-31 | 1.01 |
| 2021-09-30 | 0.45 |
| 2021-06-30 | 0.69 |
| 2021-03-31 | 0.79 |
| 2020-12-31 | 1.00 |
| 2020-09-30 | 0.98 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
